Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies

Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies

Chronic spontaneous urticaria (CSU) considerably alters patients’ quality of life, often for extended periods, due to pruriginous skin lesions, impaired sleep, unexpected development of angioedema, and failure of conventional treatments in properly controlling signs and symptoms. Recent research foc...

Full description

Bibliographic Details
Main Authors: Olguța Anca Orzan, Liliana Gabriela Popa, Mara Mădălina Mihai, Anca Cojocaru, Călin Giurcăneanu, Alexandra Maria Dorobanțu
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Medicina
Subjects:
anti-IgE antibodies
omalizumab
ligelizumab
chronic spontaneous urticaria
Online Access:https://www.mdpi.com/1648-9144/58/6/816

Similar Items

Similar Items